Skip navigation and go to main content

Commercial Manufacturing

Scale from Phase III
to Market

Our California facilities has supported the commercialization of 20+ programs over the past two decades, with peak production exceeding 1,000 lots and 2B+ dosage forms annually. At Forma, we combine hands-on manufacturing experience, strong quality systems, and practical scientific expertise to help clients confidently scale and launch their programs.

Scaling Challenges We Master

Successfully transitioning from late-phase clinical to full commercial production requires specialized expertise

Regulatory Compliance

Forma operates with established GMP-compliant systems and proven operational processes designed to help programs move forward with confidence. From product quality to controlled substance handling, our teams work proactively to ensure regulatory expectations are built into every stage of development and manufacturing.

  • Forma is fully licensed to manufacture Schedule II–V controlled drug products, with the infrastructure and operational controls needed to safely handle complex molecules. Our experienced teams help clients navigate regulatory and manufacturing challenges to confidently bring critical therapies to market.

  • Forma maintains specialized containment capabilities for safely handling high-potency APIs, supporting compounds up to OHC 3 with OELs ranging from 0.03 μg/m³ to 10 μg/m³. Our experienced teams and established containment controls help clients confidently advance potent compounds through development and manufacturing.

  • Our Irvine site builds on decades of commercial manufacturing experience, with a legacy spanning Anchen, Par Pharmaceutical, and Endo. Backed by a strong operational foundation and proven regulatory track record, the site continues to support programs from development through commercialization with confidence.

Manufacturing Capacity

Clinical to Commercial Scale

World-class infrastructure designed to meet global demand

2B+ Annual Dose Capacity

Manufacturing over two billion oral doses annually across clinical and commercial programs.

5 R&D Suites

5 dedicated non-GMP suites that allow R&D experimentation quickly and efficiently

100K Square Feet

State-of-the-art GMP facilities across two sites in California

27 GMP Suites

Dedicated manufacturing environments supporting complex oral dosage forms

Irvine, California

Facility Overview

Fairbanks Site (Irvine, CA)

  • 60,000 sq ft
  • 1,000 pallet warehouse
  • 16 GMP suites
  • Commercial scale equipment (e.g., 1,000L fluid bed granulator, 71 station tablet press)

Jeronimo Site (Irvine, CA)

  • 40,000 sq ft
  • 5,000 sq ft of GMP lab space
  • 11 GMP Suites
  • 5 dedicated R&D suites